Stay updated with breaking news from Protein Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Geneva Capital Management LLC grew its position in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 297.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,059,500 shares of the biotechnology company’s stock after purchasing an additional 793,107 shares during the quarter. Bio-Techne […]
Pfizer is planning a $470-million expansion of its Vaccine Research and Development facilities in Pearl River, NY.
S&CO Inc. increased its holdings in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 300.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 26,080 shares of the biotechnology company’s stock after acquiring an additional 19,560 shares during the quarter. S&CO Inc.’s holdings in Bio-Techne […]
Lmcg Investments LLC raised its position in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 300.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,069 shares of the biotechnology company’s stock after buying an additional 11,309 shares during the quarter. Lmcg Investments […]
StockNews.com upgraded shares of Bio-Techne (NASDAQ:TECH – Get Rating) from a hold rating to a buy rating in a research report report published on Wednesday. TECH has been the topic of several other research reports. Wells Fargo & Company upgraded shares of Bio-Techne from an underweight rating to an equal weight rating and set a […]